Mirae Asset Global Investments
BCRX icon

Mirae Asset Global Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History

Mirae Asset Global Investments’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Sell
11,367
-1,715
-13% -$15.5K ﹤0.01% 1212
2026
Q1 		$125K Buy
13,082
+2,851
+28% +$22.1K ﹤0.01% 1146
2025
Q4 		$79.8K Buy
10,231
+2,115
+26% +$15.3K ﹤0.01% 1300
2025
Q3 		$61.6K Buy
8,116
+33
+0.4% +$275 ﹤0.01% 1302
2025
Q2 		$72.4K Buy
8,083
+1,091
+16% +$10.2K ﹤0.01% 1192
2025
Q1 		$55K Buy
6,992
+90
+1% +$726 ﹤0.01% 1223
2024
Q4 		$53.2K Sell
6,902
-581
-8% -$4.41K ﹤0.01% 1259
2024
Q3 		$57K Buy
7,483
+1,322
+21% +$10K ﹤0.01% 1281
2024
Q2 		$37.6K Sell
6,161
-131,913
-96% -$728K ﹤0.01% 1296
2024
Q1 		$998K Buy
138,074
+15,894
+13% +$89.4K ﹤0.01% 1540
2023
Q4 		$732K Buy
122,180
+7,220
+6% +$41.8K ﹤0.01% 1778
2023
Q3 		$814K Sell
114,960
-7,186
-6% -$51.6K ﹤0.01% 1631
2023
Q2 		$857K Buy
122,146
+1,882
+2% +$15.1K ﹤0.01% 1656
2023
Q1 		$1M Buy
120,264
+31,018
+35% +$299K ﹤0.01% 1544
2022
Q4 		$1.02M Buy
89,246
+77
+0.1% +$960 ﹤0.01% 1481
2022
Q3 		$1.12M Buy
89,169
+33,334
+60% +$429K ﹤0.01% 1426
2022
Q2 		$591K Buy
+55,835
New +$576K ﹤0.01% 1669

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's BCRX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its BioCryst Pharmaceuticals (BCRX) stake by 13% in Q2 2026, selling an estimated $15.5K and leaving 11,367 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #1212.

Mirae Asset Global Investments first reported a position in BCRX in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.12M in Q3 2022. 115 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Mirae Asset Global Investments held 11,367 shares of BioCryst Pharmaceuticals worth $114K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,715 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $15.5K.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1212 holding.
  • Mirae Asset Global Investments first reported a position in BioCryst Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's BioCryst Pharmaceuticals position peaked at $1.12M in Q3 2022.
  • 115 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.